A pharmacometrics model to define docetaxel target in early breast cancer

Aims: We aimed to study the relation between pharmacokinetics (PK) and pharmacodynamics (PD) of docetaxel in early breast cancer and recommend a target exposure. Methods: A PK/PD study was performed in 27 early breast cancer patients treated with doxorubicin and cyclophosphamide for 4 cycles foll...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Aldaz, A. (Azucena), Schaiquevich, P. (Paula), Aramendia, J.M. (J.M.)
Materialtyp: info:eu-repo/semantics/article
Språk:eng
Publicerad: Wiley 2023
Ämnen:
Länkar:https://hdl.handle.net/10171/66083